Zoetis Inc. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Zoetis Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2019-03-31 was 0.00 shares.
- Zoetis Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2018-12-31 was 0.00 shares.
- Zoetis Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2018-09-30 was 0.00 shares.
- Zoetis Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2018-06-30 was 0.00 shares.
- Zoetis Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2018 was 0.00 shares.
- Zoetis Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2017 was 0.00 shares, a 100.00% decline from fiscal 2016.
- Zoetis Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2016 was 83.00K shares, a 82.19% decline from fiscal 2015.
- Zoetis Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2015 was 466.00K shares.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-02 | 0.00 shares derived: sum of 4 quarters · filed 2019-05-02 |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | 0.00 shares 10-K · filed 2019-02-14 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | 0.00 shares derived: sum of 4 quarters · filed 2019-05-02 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 0.00 shares derived: sum of 4 quarters · filed 2019-05-02 |
| 2018-03-31 | 0.00 shares 10-Q · filed 2019-05-02 | 0.00 shares derived: sum of 4 quarters · filed 2019-05-02 |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | 0.00 shares 10-K · filed 2018-02-15 |
| 2017-10-01 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | 3.00K shares derived: sum of 4 quarters · filed 2018-11-01 |
| 2017-07-02 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 3.00K shares derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-04-02 | 0.00 shares 10-Q · filed 2018-05-02 | 3.00K shares derived: sum of 4 quarters · filed 2018-05-02 |
| 2016-12-31 | 3.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | 83.00K shares 10-K · filed 2017-02-16 |
| 2016-10-02 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | 316.00K shares derived: sum of 4 quarters · filed 2017-11-02 |
| 2016-07-03 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 386.00K shares derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-04-03 | 80.00K shares 10-Q · filed 2017-05-04 | 436.00K shares derived: sum of 4 quarters · filed 2017-05-04 |
| 2015-12-31 | 236.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | 466.00K shares 10-K · filed 2016-02-24 |
| 2015-09-27 | 70.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | |
| 2015-06-28 | 50.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | |
| 2015-03-29 | 110.00K shares 10-Q · filed 2016-05-06 | |
| 2014-09-28 | 14.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | |
| 2014-06-29 | 53.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | |
| 2014-03-30 | 33.00K shares 10-Q · filed 2015-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |